Hims & Hers Health (HIMS) to Report Q4 Earnings Amid Stock Slump

Hims & Hers Health (NYSE: HIMS) is scheduled to release its fourth-quarter earnings results after the market closes on Monday, February 23, 2026. The report arrives following a 46.7% decline in share price over the last month, significantly underperforming the healthcare technology sector's average loss of 3.2%. Analysts project revenue growth of 28.4% year-over-year, a deceleration from the 95.1% surge recorded in the same period last year. In the previous quarter, the telehealth company reported revenues of $599 million, beating expectations but issuing forward guidance that missed analyst estimates. Despite the recent volatility, analysts have largely reconfirmed their estimates over the last 30 days. The consensus price target stands at $27.46, compared to the current trading price of $15.78.